Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shandong Pharmaceutical Glass CoSHSE:600529 -0.31%92 Cyclically Adjusted PB Ratio is 2.21 as of Aug. 26, 2026, which is 43% below its 10-year median of 3.85. GuruFocus rates SHSE:600529 with a GF Score™ of 92/100 and a GF Value™ of ¥23.45 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 277 Packaging & Containers companies, Shandong Pharmaceutical Glass Co ranks worse than 73.65% on this metric.
The historical rank and industry rank for Shandong Pharmaceutical Glass Co's Cyclically Adjusted PB Ratio or its related term are showing as below:
SHSE:600529'
s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 2.08 Med: 3.85 Max: 13.97
Current: 2.21
During the past years, Shandong Pharmaceutical Glass Co's highest Cyclically Adjusted PB Ratio was 13.97. The lowest was 2.08. And the median was 3.85.
SHSE:600529's Cyclically Adjusted PB Ratio is ranked worse than 73.65% of 277
companies
in the Packaging & Containers industry
Industry Median: 1.17
vs SHSE:600529: 2.21
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.
Shandong Pharmaceutical Glass Co's adjusted book value per share data for the three months ended in Jun. 2026 was ¥12.877. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥8.68 for the trailing ten years ended in Jun. 2026.
Shiller PE for Stocks: The True Measure of Stock Valuation
Shandong Pharmaceutical Glass Co (SHSE:600529) Cyclically Adjusted PB Ratio Explanation
Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.
Shandong Pharmaceutical Glass Co Cyclically Adjusted PB Ratio Related Terms
Shandong Pharmaceutical Glass Co Cyclically Adjusted PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Pharmaceutical Glass Co Cyclically Adjusted PB Ratio Chart
SHSE:600529 vs SW, PKG, IP: Cyclically Adjusted PB Ratio Comparison
For the Packaging & Containers subindustry, Shandong Pharmaceutical Glass Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shandong Pharmaceutical Glass Co Cyclically Adjusted PB Ratio vs Packaging & Containers Industry
For the Packaging & Containers industry and Consumer Cyclical sector, Shandong Pharmaceutical Glass Co's Cyclically Adjusted PB Ratio distribution charts can be found below:
* The bar in red indicates where Shandong Pharmaceutical Glass Co's Cyclically Adjusted PB Ratio falls into.
Shandong Pharmaceutical Glass Co Cyclically Adjusted PB Ratio Calculation
Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
What does a Cyclically Adjusted PB Ratio of 2.21 mean?
Shandong Pharmaceutical Glass Co (SHSE:600529) has a Cyclically Adjusted PB Ratio of 2.21 as of Aug. 26, 2026. Cyclically Adjusted PB Ratio is the ratio of share price to a company's inflation-adjusted book value per share over a 10-year period. View historical data on Shandong Pharmaceutical Glass Co and its competitors. This is 43% below median its historical median of 3.85. Over the past decade, Shandong Pharmaceutical Glass Co's Cyclically Adjusted PB Ratio has ranged from 2.08 to 13.97. According to the industry distribution chart, Shandong Pharmaceutical Glass Co ranks #204 out of 277 companies in the Packaging & Containers industry, placing it in the top 73.6%.
Is Shandong Pharmaceutical Glass Co's Cyclically Adjusted PB Ratio too high?
Shandong Pharmaceutical Glass Co's current Cyclically Adjusted PB Ratio of 2.21 is 43% below median its 10-year median of 3.85. Over the past 10 years, this metric has ranged from a low of 2.08 to a high of 13.97. The Packaging & Containers industry median Cyclically Adjusted PB Ratio is 1.17. Shandong Pharmaceutical Glass Co's value of 2.21 is 88.9% above this industry median. Based on the distribution chart, Shandong Pharmaceutical Glass Co ranks #204 out of 277 companies in the Packaging & Containers industry, which is below the industry midpoint. Overall, Shandong Pharmaceutical Glass Co has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shandong Pharmaceutical Glass Co's Cyclically Adjusted PB Ratio compare to SW and PKG?
According to the Packaging & Containers industry distribution chart, Shandong Pharmaceutical Glass Co ranks #204 out of 277 companies for Cyclically Adjusted PB Ratio. This places Shandong Pharmaceutical Glass Co in the lower half of its industry. The industry median Cyclically Adjusted PB Ratio is 1.17. Shandong Pharmaceutical Glass Co's value of 2.21 is 88.9% above this benchmark. Historically, Shandong Pharmaceutical Glass Co's own Cyclically Adjusted PB Ratio has ranged from 2.08 to 13.97 over the past decade. While the company's 10-year median is 3.85 vs. the industry median of 1.17, Shandong Pharmaceutical Glass Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PB Ratio for a Packaging & Containers company?
The median Cyclically Adjusted PB Ratio among Packaging & Containers companies is 1.17, based on 277 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shandong Pharmaceutical Glass Co's current Cyclically Adjusted PB Ratio of 2.21 is 88.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PB Ratio mean?
A high Cyclically Adjusted PB Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PB Ratio is the ratio of share price to a company's inflation-adjusted book value per share over a 10-year period. View historical data on Shandong Pharmaceutical Glass Co and its competitors. For the Packaging & Containers industry, the median Cyclically Adjusted PB Ratio is 1.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shandong Pharmaceutical Glass Co's current Cyclically Adjusted PB Ratio is 2.21, which is 43% below median its own 10-year median of 3.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Pharmaceutical Glass Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Pharmaceutical Glass Co (SHSE:600529) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥23.45, compared to a current price of ¥19.16 — trading 18.3% below its estimated fair value. The current Cyclically Adjusted PB Ratio is 2.21, which is 43% below median its 10-year median of 3.85 and 88.9% above the Packaging & Containers industry median of 1.17. Shandong Pharmaceutical Glass Co's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PB Ratio calculated?
Cyclically Adjusted PB Ratio is calculated from a company's financial statements. For Shandong Pharmaceutical Glass Co (SHSE:600529), the current Cyclically Adjusted PB Ratio is 2.21 as of Aug. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shandong Pharmaceutical Glass Co (SHSE:600529) Overvalued in 2026?
Based on GuruFocus' analysis, Shandong Pharmaceutical Glass Co stock appears to be undervalued.
The current stock price of ¥19.16 is trading 18.3% below its estimated GF Value™ of ¥23.45.
GuruFocus considers Shandong Pharmaceutical Glass Co to be Modestly Undervalued.
Key valuation signals for SHSE:600529:
Cyclically Adjusted PB Ratio: 2.21 (43% below median its 10-year median of 3.85)
GF Value™: ¥23.45 vs. price of ¥19.16 (18.3% below fair value)
Industry Position: 88.9% above the Packaging & Containers median (#204 of 277)
No single metric tells the full story. See the SHSE:600529 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shandong Pharmaceutical Glass Co Ltd is a pharmaceutical glass packaging product company. Its pharmaceutical glass packaging products and butyl rubber series products which service object of pharmaceutical, food, daily necessities industries. The products include for moulded injection vial for antibiotics series, tubular glass vial series, amber glass bottle series, neutral borosilicate glass bottle series, infusion bottle series, cosmetic bottles series, food bottles series, butyl rubber stopper series, prefillable syringes series, and aluminum-plastic cap series.
92GF Score
Get the complete analysis for SHSE:600529
Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600529 has been successfully added to your 
